Transgelin-2 in immunity: Its implication in cell therapy S Jo, HR Kim, YV Mun, CD Jun Journal of leukocyte biology 104 (5), 903-910, 2018 | 36 | 2018 |
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation R Wu, RA Ohara, S Jo, TT Liu, ST Ferris, F Ou, S Kim, DJ Theisen, ... Nature immunology 23 (11), 1536-1550, 2022 | 32 | 2022 |
Single-cell deletion analyses show control of pro–T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b W Zhou, F Gao, M Romero-Wolf, S Jo, EV Rothenberg Science immunology 7 (71), eabm1920, 2022 | 27 | 2022 |
IL-6 selectively suppresses cDC1 specification via C/EBPβ S Kim, J Chen, S Jo, F Ou, ST Ferris, TT Liu, RA Ohara, DA Anderson III, ... Journal of Experimental Medicine 220 (10), e20221757, 2023 | 4 | 2023 |
Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand F Ou, ST Ferris, S Kim, R Wu, DA Anderson III, TT Liu, S Jo, MY Chen, ... European journal of immunology 53 (9), 2250201, 2023 | 1 | 2023 |
Single-cell perturbation dissects transcription factor control of progression speed and trajectory choice in early T-cell development W Zhou, F Gao, M Romero-Wolf, S Jo, EV Rothenberg BioRxiv, 2021.09. 03.458944, 2021 | 1 | 2021 |
Transcription factor C/EBPα is required for the development of Ly6Chi monocytes but not Ly6Clo monocytes S Kim, J Chen, F Ou, TT Liu, S Jo, WE Gillanders, TL Murphy, KM Murphy Proceedings of the National Academy of Sciences 121 (15), e2315659121, 2024 | | 2024 |
Suggested searches E Axell, J Hu, M Lindberg, AJ Dear, L Ortigosa-Pascual, EA Andrzejewska, ... Perspective, 2024 | | 2024 |